Advicenne Reports 2021 Half Year Financial Results

September 29, 2021

Paris, France, 29 September 2021 – 7:00AM (CEST) – Advicenne (Euronext: ADVIC), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, today announces the publication of its financial results for the six months ending on June 30, 2021.